NVST
Price
$19.39
Change
-$0.36 (-1.82%)
Updated
Jul 18, 02:08 PM (EDT)
Capitalization
3.67B
13 days until earnings call
PODD
Price
$284.38
Change
+$1.09 (+0.38%)
Updated
Jul 18, 02:11 PM (EDT)
Capitalization
11.75B
20 days until earnings call
Interact to see
Advertisement

NVST vs PODD

Header iconNVST vs PODD Comparison
Open Charts NVST vs PODDBanner chart's image
Envista Holdings
Price$19.39
Change-$0.36 (-1.82%)
Volume$400
Capitalization3.67B
Insulet
Price$284.38
Change+$1.09 (+0.38%)
Volume$100
Capitalization11.75B
NVST vs PODD Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. PODD commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and PODD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (NVST: $19.75 vs. PODD: $283.45)
Brand notoriety: NVST and PODD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVST: 57% vs. PODD: 76%
Market capitalization -- NVST: $3.67B vs. PODD: $11.75B
NVST [@Medical Specialties] is valued at $3.67B. PODD’s [@Medical Specialties] market capitalization is $11.75B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whilePODD’s FA Score has 1 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • PODD’s FA Score: 1 green, 4 red.
According to our system of comparison, PODD is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 3 TA indicator(s) are bullish while PODD’s TA Score has 4 bullish TA indicator(s).

  • NVST’s TA Score: 3 bullish, 5 bearish.
  • PODD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PODD is a better buy in the short-term than NVST.

Price Growth

NVST (@Medical Specialties) experienced а -4.68% price change this week, while PODD (@Medical Specialties) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.34%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was -1.82%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

PODD is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (-0.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PODD($11.8B) has a higher market cap than NVST($3.67B). PODD has higher P/E ratio than NVST: PODD (57.17) vs NVST (21.74). PODD YTD gains are higher at: 8.572 vs. NVST (2.385). PODD has higher annual earnings (EBITDA): 324M vs. NVST (171M). NVST has more cash in the bank: 940M vs. PODD (704M). PODD has less debt than NVST: PODD (1.42B) vs NVST (1.65B). NVST has higher revenues than PODD: NVST (2.57B) vs PODD (1.7B).
NVSTPODDNVST / PODD
Capitalization3.67B11.8B31%
EBITDA171M324M53%
Gain YTD2.3858.57228%
P/E Ratio21.7457.1738%
Revenue2.57B1.7B151%
Total Cash940M704M134%
Total Debt1.65B1.42B117%
FUNDAMENTALS RATINGS
NVST vs PODD: Fundamental Ratings
NVST
PODD
OUTLOOK RATING
1..100
8268
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9626
PRICE GROWTH RATING
1..100
4649
P/E GROWTH RATING
1..100
8670
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (63) in the null industry is in the same range as PODD (89) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PODD’s over the last 12 months.

PODD's Profit vs Risk Rating (68) in the Medical Specialties industry is in the same range as NVST (100) in the null industry. This means that PODD’s stock grew similarly to NVST’s over the last 12 months.

PODD's SMR Rating (26) in the Medical Specialties industry is significantly better than the same rating for NVST (96) in the null industry. This means that PODD’s stock grew significantly faster than NVST’s over the last 12 months.

NVST's Price Growth Rating (46) in the null industry is in the same range as PODD (49) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PODD’s over the last 12 months.

PODD's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as NVST (86) in the null industry. This means that PODD’s stock grew similarly to NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTPODD
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 9 days ago
67%
Bullish Trend 19 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAVGX25.44N/A
N/A
Haverford Quality Growth Stock
VWNEX72.37N/A
N/A
Vanguard Windsor™ Admiral™
SECUX37.54N/A
N/A
NAA Mid Growth A
ETCGX46.15N/A
N/A
Eventide Gilead C
BIVIX16.83N/A
N/A
Invenomic Institutional

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with ALGN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+0.15%
ALGN - NVST
65%
Loosely correlated
+1.07%
A - NVST
56%
Loosely correlated
+2.58%
MTD - NVST
55%
Loosely correlated
+1.81%
XRAY - NVST
54%
Loosely correlated
-0.19%
RVTY - NVST
53%
Loosely correlated
+0.72%
More

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
-1.67%
ISRG - PODD
47%
Loosely correlated
+0.69%
BSX - PODD
45%
Loosely correlated
+1.41%
SYK - PODD
40%
Loosely correlated
-0.50%
MMSI - PODD
39%
Loosely correlated
+0.70%
PEN - PODD
35%
Loosely correlated
-1.84%
More